Skip to content
Search

Latest Stories

Antibiotic prescribing increases by over 8% in England

Deaths due to severe antibiotic resistant infections have also increased in the country

The UK Health Security Agency (UKHSA) has published the latest national surveillance data on antibiotic prescribing and resistance.


The English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report showed an increase in antibiotic use in all settings (apart from dental) in 2022.

According to the report, antibiotic prescribing rose by 8.4 per cent in 2022 compared with 2021, although the number remains below 2019 pre-pandemic levels.

“There are many reasons behind the increase in prescribing, one of which is likely related to decreased immunity and exposure to infections during the COVID-19 pandemic that may have underpinned the increased transmission in co-circulating infections, namely: influenza (flu), respiratory syncytial virus (RSV) and group A streptococcus (GAS),” the report stated.

An estimated 58,224 people in England had an antibiotic-resistant infection in 2022, an increase of 4 per cent since 2021 (55,792).

There were 2,202 deaths due to severe antibiotic-resistant infections in 2022, compared to 2,110 deaths the previous year.

Commenting on the report, Professor Dame Jenny Harries, Chief Executive of UKHSA, said: “Antimicrobial resistance is not a crisis of the future, but one that is very much with us right now.

“We expect that if we get a bacterial infection, an antibiotic will be available to treat us – but sometimes, already, that is simply impossible. Unless action is taken the availability of life-saving treatments will only diminish and our ability to drive down infections will decrease, most likely impacting those in the poorest social circumstances worst,” she added.

Side effects of inappropriate and excessive antibiotic use

The health agency has cautioned that inappropriate and excessive antibiotic use can increase the risk of the emergence of antibiotic-resistant bacteria and deaths related to these infections.

“Antibiotic-resistant bacteria are less likely to respond to treatment, causing serious complications, including bloodstream infections, sepsis and hospitalisation,” it said.

Further, the report cited increases in antibiotic resistance in some bacteria, particularly Klebsiella pneumoniae, which can cause sepsis.

The bacterium is becoming increasingly resistant to a range of antibiotics traditionally used as first line treatments, including third generation-cephalosporins and piperacillin with tazobactam.

Asian or Asian British ethnic groups had almost double the proportion of antibiotic-resistant infections (34.6%) compared to white ethnic groups (18.7%).

People who get a bacterial infection that is resistant to one or more antibiotics are more likely to die from their infection compared to those who have an antibiotic sensitive infection.

Hence, the agency has warned people to “take antibiotics only when they are prescribed and necessary for the condition.”

How you can help keep antibiotics working

Professor Harries suggested two things that everyone can do to help keep antibiotics working.

  • First, you can help reduce or prevent infections by taking simple steps like staying away from vulnerable people if you are feeling unwell, washing your hands regularly and keeping rooms ventilated.
  • Second, only take antibiotics if you have been told to do so by a healthcare professional, and do not save some for later or share them with friends and family.

The professor also reminded people that “antibiotics will not work for viruses such as cold, flu or COVID-19.”

More For You

Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less